Aldeyra Therapeutics Inc (NASDAQ:ALDX)
| 9.01 Delayed Data As of Mar 24 |  -0.05 / -0.55%Today’s Change | 2.36 Today|||52-Week Range 9.20 | +29.45% Year-to-Date |
Latest ALDX News | Press Releases
No recent news for Aldeyra Therapeutics Inc.
Today’s Trading
| Previous close | 9.06 |
| Today’s open | 9.01 |
| Day’s range | 8.66 - 9.11 |
| Volume | 84,547 |
| Average volume (3 months) | 436,452 |
| Market cap | $442.8M |
Data as of 4:00pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +0.66% |
| Earnings growth (this year) | -37.44% |
| Earnings growth (next 5 years) | +57.80% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | +0.17 | +3.25% |
| BTAIBioXcel Therapeutics... | +0.05 | +0.27% |
| NVAXNovavax Inc | +0.31 | +5.38% |
| MORMorphoSys AG | +0.01 | +0.25% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$62.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
